Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03983915Unknown
Randomised, open-label trial of dexmedetomidine and remifentanil in Respiratory diseases (2 arms), sponsored by Changhai Hospital. Primary endpoint: Recovery time up to 3 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03983915.